RFK Jr.'s Panel Gives Update on Reviewing Childhood Vaccine Schedule
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources.
Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content.
A newly restructured panel of vaccine advisers to the Centers for Disease Control and Prevention (CDC) plans to launch new work groups tasked with evaluating the effects of the childhood and adolescent immunization schedules, the first hepatitis B dose administered at birth, and the combined measles, mumps, rubella, and varicella (MMRV) vaccine.
The newly appointed chair of the Advisory Committee on Immunization Practices (ACIP), Dr. Martin Kulldorff, made the announcement during Wednesday's meeting in Atlanta, according to CNN.
This marked the first gathering of the revised ACIP since U.S. Health and Human Services Secretary Robert F. Kennedy Jr. dismissed the previous 17-member panel earlier this month, citing alleged conflicts of interest. He swiftly replaced them with eight new members, though one later withdrew during a financial disclosure review, according to the Associated Press, leaving seven individuals now responsible for advising the nation on vaccine recommendations.
The American Academy of Pediatrics announced at the meeting that it will continue publishing its own vaccine schedule for children but now will do so independently of the ACIP, calling it "no longer a credible process."
This is a breaking news story. Updates to follow.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNN
2 hours ago
- CNN
With federal support uncertain, states and nonprofits scramble to safeguard access to vaccines
Vaccines Children's healthFacebookTweetLink Follow After recent moves by the US Department of Health and Human Services to restrict the approval and use of some vaccines — and signs that more changes might be coming — some states and private partnerships are scrambling to ensure that vaccines will still be available to those who want them. People familiar with various efforts that are underway described them as necessary but not ideal. 'When you start splintering the message from the federal government down states and local health departments, people end up losing faith in everybody. They don't know who to believe,' said one official familiar with several ongoing efforts who spoke on the condition they not be named because they weren't authorized to share the details of those plans. Several groups, for example, are working to create panels of subject matter experts who would review the latest science behind vaccines and make evidence-based recommendations for their use, much like the US Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices, or ACIP, has done for the past 60 years. Nine states have banded together to create the Northeast Public Health Collaboration, which is staffed by state and city health officials. The group is organized into committees, and their work has intensified quickly in response to shifting federal health priorities and deep cuts to health agencies, according to a person familiar with the group who was not authorized to share the details of their plans. 'They're specifically looking at how, as a collaborative of states, they can address gaps in federal support and resources moving forward in key public health areas,' the person said. One of the areas they're preparing to address is flagging federal support for vaccines, but the member states also have efforts underway to address pandemic preparedness, laboratory services, epidemiology and other key public health priorities. One state represented in that group, Maine, has even recently struck language in its vaccine access law referencing ACIP and created a pathway to purchase vaccines outside of the federal Vaccines for Children Program, which provides vaccines for free to children whose families can't afford them, and which public health advocates fear may also be under threat. Organizers for the effort declined to offer many specifics about the collaboration. They described their work as being in an early stage and said the collaboration was intended only to share information between partners. They stressed that it was not intended to replace or duplicate any federal programs. 'New York state maintains its commitment to protecting access to essential public health services and regularly engages in informal conversations with other states to share information and best practices on public health preparedness,' said a spokesperson for the New York State Department of Health, one of the states involved in the effort. The Massachusetts Department of Health also declined to share more specific details about the collaboration but issued a statement: 'The Department of Public Health is committed to maintaining access to evidence-based vaccines for all people in the state. As federal policy decisions are proposed and enacted that impact vaccine infrastructure, Massachusetts is evaluating what may be necessary to have undisrupted access.' Like Maine, Colorado recently passed legislation to protect coverage for a range of preventive services, including vaccines. In the event the federal government repeals, modifies or gets rid of recommendations for preventive services made by ACIP, the US Preventive Services Task Force or the Health Resources and Services Administration, the new law gives the state's health commissioner leeway to make rules based off recommendations as they existed in January. HHS Secretary Robert F. Kennedy Jr.'s decision to bypass ACIP's process and change the recommendations for Covid-19 vaccines for healthy children and pregnant women in May was a red flag for vaccine access, according to a source familiar with the deliberations of state health departments who asked not to be named because they were not authorized to share the details of those discussions. His subsequent decision to dismiss all 17 sitting members of ACIP and replace them with eight of his own choices, including several new members who have expressed doubts about the safety and effectiveness of vaccines, spurred the drive for change at the state level, the official said. 'I think states are concerned that, based on these early indications, potentially there will be some new challenges for them in terms of being able to support and offer vaccines,' the official said, 'and so I think they are trying to think of different ways in this new environment that we're in that they still are able to provide vaccines.' ACIP's recommendations are intertwined with state laws in numerous ways, according to the Association of State and Territorial Health Officials, which created a reference list. For example, several states – including Minnesota, Vermont and Maine – have laws that allow pharmacists and even dentists to give vaccines as long as they're recommended by ACIP. Changing those recommendations could affect the ability of pharmacists or other health care providers to deliver certain shots. States like New Mexico, Missouri and Alabama tie their requirements for public school enrollment to the most recent version of ACIP's recommendations. Additionally, states sometimes require educational materials for vaccines to hew to ACIP recommendations. Tennessee, for example, requires hospitals to provide parents of newborns with information about pertussis, or whooping cough, and about the availability of a vaccine for pertussis, using information that's in line with ACIP recommendations. Beyond state efforts, there are nonprofit startups working to maintain vaccine access. One such effort is the Vaccine Integrity Project, which is being coordinated by the Center for Infectious Disease Research and Policy at the University of Minnesota and supported by an unrestricted grant from Walmart heiress Christy Walton. The group's steering committee comprises medical and public health experts, former elected officials and former leaders of federal agencies. The initiative aims to counter disinformation around vaccines and provide updated guidelines on their use based on evolving science and safety information. It's also seeking to work with states to help them identify ways their vaccine access laws and funding mechanisms may need to change so they can continue to deliver vaccines to their health care providers and pharmacies. 'The emergence of organizations that collaborate to help fill the gap in the federal government is happening, and it needs to happen,' said Lori Tremmel Freeman, chief executive officer of the National Association of County and City Health Officials. 'We have to be very forward-thinking about it, because these are programs and services that impact every community in this country in different ways, some more than others. And therefore the impact of programs and services being reduced or whole scale being removed or going away is not known, but we can be sure it will impact the health of every community in this country,' Freeman said.
CNN
2 hours ago
- CNN
With federal support uncertain, states and nonprofits scramble to safeguard access to vaccines
After recent moves by the US Department of Health and Human Services to restrict the approval and use of some vaccines — and signs that more changes might be coming — some states and private partnerships are scrambling to ensure that vaccines will still be available to those who want them. People familiar with various efforts that are underway described them as necessary but not ideal. 'When you start splintering the message from the federal government down states and local health departments, people end up losing faith in everybody. They don't know who to believe,' said one official familiar with several ongoing efforts who spoke on the condition they not be named because they weren't authorized to share the details of those plans. Several groups, for example, are working to create panels of subject matter experts who would review the latest science behind vaccines and make evidence-based recommendations for their use, much like the US Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices, or ACIP, has done for the past 60 years. Nine states have banded together to create the Northeast Public Health Collaboration, which is staffed by state and city health officials. The group is organized into committees, and their work has intensified quickly in response to shifting federal health priorities and deep cuts to health agencies, according to a person familiar with the group who was not authorized to share the details of their plans. 'They're specifically looking at how, as a collaborative of states, they can address gaps in federal support and resources moving forward in key public health areas,' the person said. One of the areas they're preparing to address is flagging federal support for vaccines, but the member states also have efforts underway to address pandemic preparedness, laboratory services, epidemiology and other key public health priorities. One state represented in that group, Maine, has even recently struck language in its vaccine access law referencing ACIP and created a pathway to purchase vaccines outside of the federal Vaccines for Children Program, which provides vaccines for free to children whose families can't afford them, and which public health advocates fear may also be under threat. Organizers for the effort declined to offer many specifics about the collaboration. They described their work as being in an early stage and said the collaboration was intended only to share information between partners. They stressed that it was not intended to replace or duplicate any federal programs. 'New York state maintains its commitment to protecting access to essential public health services and regularly engages in informal conversations with other states to share information and best practices on public health preparedness,' said a spokesperson for the New York State Department of Health, one of the states involved in the effort. The Massachusetts Department of Health also declined to share more specific details about the collaboration but issued a statement: 'The Department of Public Health is committed to maintaining access to evidence-based vaccines for all people in the state. As federal policy decisions are proposed and enacted that impact vaccine infrastructure, Massachusetts is evaluating what may be necessary to have undisrupted access.' Like Maine, Colorado recently passed legislation to protect coverage for a range of preventive services, including vaccines. In the event the federal government repeals, modifies or gets rid of recommendations for preventive services made by ACIP, the US Preventive Services Task Force or the Health Resources and Services Administration, the new law gives the state's health commissioner leeway to make rules based off recommendations as they existed in January. HHS Secretary Robert F. Kennedy Jr.'s decision to bypass ACIP's process and change the recommendations for Covid-19 vaccines for healthy children and pregnant women in May was a red flag for vaccine access, according to a source familiar with the deliberations of state health departments who asked not to be named because they were not authorized to share the details of those discussions. His subsequent decision to dismiss all 17 sitting members of ACIP and replace them with eight of his own choices, including several new members who have expressed doubts about the safety and effectiveness of vaccines, spurred the drive for change at the state level, the official said. 'I think states are concerned that, based on these early indications, potentially there will be some new challenges for them in terms of being able to support and offer vaccines,' the official said, 'and so I think they are trying to think of different ways in this new environment that we're in that they still are able to provide vaccines.' ACIP's recommendations are intertwined with state laws in numerous ways, according to the Association of State and Territorial Health Officials, which created a reference list. For example, several states – including Minnesota, Vermont and Maine – have laws that allow pharmacists and even dentists to give vaccines as long as they're recommended by ACIP. Changing those recommendations could affect the ability of pharmacists or other health care providers to deliver certain shots. States like New Mexico, Missouri and Alabama tie their requirements for public school enrollment to the most recent version of ACIP's recommendations. Additionally, states sometimes require educational materials for vaccines to hew to ACIP recommendations. Tennessee, for example, requires hospitals to provide parents of newborns with information about pertussis, or whooping cough, and about the availability of a vaccine for pertussis, using information that's in line with ACIP recommendations. Beyond state efforts, there are nonprofit startups working to maintain vaccine access. One such effort is the Vaccine Integrity Project, which is being coordinated by the Center for Infectious Disease Research and Policy at the University of Minnesota and supported by an unrestricted grant from Walmart heiress Christy Walton. The group's steering committee comprises medical and public health experts, former elected officials and former leaders of federal agencies. The initiative aims to counter disinformation around vaccines and provide updated guidelines on their use based on evolving science and safety information. It's also seeking to work with states to help them identify ways their vaccine access laws and funding mechanisms may need to change so they can continue to deliver vaccines to their health care providers and pharmacies. 'The emergence of organizations that collaborate to help fill the gap in the federal government is happening, and it needs to happen,' said Lori Tremmel Freeman, chief executive officer of the National Association of County and City Health Officials. 'We have to be very forward-thinking about it, because these are programs and services that impact every community in this country in different ways, some more than others. And therefore the impact of programs and services being reduced or whole scale being removed or going away is not known, but we can be sure it will impact the health of every community in this country,' Freeman said.
CNBC
2 hours ago
- CNBC
Moderna's flu vaccine shows positive late-stage trial results, paving way for combination Covid shot
Moderna on Monday said its experimental mRNA-based flu vaccine produced a stronger immune response than a currently available shot in a late-stage trial, clearing a path forward for the product and the company's separate combination flu and Covid jab. Moderna in May voluntarily withdrew an application seeking approval of its combination shot targeting Covid-19 and influenza, saying it had plans to resubmit it with efficacy data from the phase three trial on its standalone flu vaccine. That decision came after discussions with the Food and Drug Administration, which is grappling with a massive overhaul under Health and Human Services Secretary Robert F. Kennedy Jr., a prominent vaccine skeptic. With the new data, the company plans to resubmit the application for the combination vaccine and file for approval of its standalone flu shot later this year, Stephen Hoge, the company's head of research and development, said in an interview. If regulators approve the flu vaccine, the company can then advance the combination shot, Hoge said. He added that Moderna expects approvals for both shots next year pending reviews. He said the combination jab simplifies vaccination, which will "help the health-care system" by reducing workloads of doctors and nurses, slashing costs and improving uptake among patients. The company so far appears to be the frontrunner in the race against Pfizer and Novavax to bring a combination shot to the market. While Moderna does not have specific revenue projections for its individual products, Hoge said Covid, flu and respiratory syncytial virus are each multi-billion-dollar markets. "We're obviously hoping that our products allow us to earn our fair share of them," he said. The phase three trial followed more than 40,000 adults ages 50 and above, who were randomly assigned to receive a single dose of Moderna's shot, called mRNA-1010, or a standard competitor vaccine. Moderna's shot was 26.6% more effective than the other vaccine in the overall study population. The mRNA-1010 jab also demonstrated strong efficacy for each of the major influenza strains in the shot, including A/H1N1, A/H3N2 and the B/Victoria lineages. Moderna said the vaccine's benefit was consistent across different age groups, people with various risk factors and previous vaccination status against the flu. In adults ages 65 and older, the shot was 27.4% more effective than the standard flu vaccine. The efficacy results are "a significant milestone in our effort to reduce the burden of influenza in older adults," Moderna CEO Stephane Bancel said in a release. "The severity of this past flu season underscores the need for more effective vaccines." Moderna cited data from the Centers for Disease Control and Prevention showing that seasonal flu-related hospitalizations and outpatient visits reached a 15-year high during the 2024 to 2025 season of the virus. More than 600,000 Americans were hospitalized due to flu-related illness last year, according to the CDC. The mRNA-1010 vaccine's safety data was consistent with previous results from another phase three study on the shot. Shares of Moderna are down more than 30% for the year, fueled in large part by a string of moves by the Trump administration to change vaccine policy and undermine immunizations. The administration in May canceled a contract awarded to Moderna for the late-stage development of its bird flu vaccine for humans. When asked about the uncertain regulatory environment in the U.S., Hoge said Moderna is engaging closely with the FDA to understand what its requirements are and how to satisfy them. "I believe, as relates to flu, I think we've got a pretty clear path," he said.
